Actively Recruiting
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
Led by Nutraceuticals Research Institute · Updated on 2025-04-09
70
Participants Needed
1
Research Sites
34 weeks
Total Duration
On this page
Sponsors
N
Nutraceuticals Research Institute
Lead Sponsor
C
ChromaDex, Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study evaluates the subjective effects of injection administration of NR on healthy adult populations.
CONDITIONS
Official Title
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed and dated informed consent form
- Willingness and ability to comply with all study procedures and availability for the study duration
- Lives within 100 miles of the NRI study site
- Any gender, aged 40 to 65 years inclusive
- Good general health based on medical history
- Body mass index (BMI) between 25 and 34.9 kg/m2
- Sedentary behavior defined as less than 20 minutes per day or 100 minutes per week of moderate to vigorous exercise
- Demonstrated fatigue with a below-average score on the Fatigue Assessment Scale
- For females of reproductive potential: use of highly effective contraception for at least 1 month prior to screening and agreement to use it during the study and for 1 month after
- Agreement to follow lifestyle considerations during the study
You will not qualify if you...
- Current diagnosis of seizure disorder, diabetes or insulin resistance, kidney or liver disorder, heart disease, anemia, cancer, or Parkinson's disease
- Any chronic illness (pre-disease state allowed)
- Out of range phosphate levels at baseline
- BMI less than 25 or greater than or equal to 35
- Pregnancy, trying to conceive, or breastfeeding
- Known allergic reactions to any intervention components, including any form of vitamin B3
- Positive COVID-19 test within 30 days of the study
- Recent significant weight changes (10% body weight change in last 6 months)
- Use of NAD+ or NAD precursor supplements, including B-complex, within 60 days before the study, excluding multivitamins
- Starting new medications, supplements, investigational drugs, or lifestyle changes within 60 days before the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nutraceuticals Research Institute
Huntsville, Alabama, United States, 35801
Actively Recruiting
Research Team
J
JESSIE HAWKINS, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
9
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here